Quick Answer
Journey Medical Corp reported Research And Development Expense of $480.0 thousand for the year ending 2025.
- Journey Medical Corp showed a decrease of -95.1% in Research And Development Expense from 2024 to 2025.
- This data is from Journey Medical Corp's annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), Journey Medical Corp's Research And Development Expense has declined by 82.5%.
- Historical annual values: Fiscal year 2025: $480.0 thousand | Fiscal year 2024: $9.86 million | Fiscal year 2023: $7.54 million | Fiscal year 2022: $10.94 million | Fiscal year 2021: $2.74 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: